Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jalal Dahham, Mickaël Hiligsmann, Ingrid Kremer, Samia J. Khoury, Hala Darwish, Hassan Hosseini, Silvia Evers & Rana Rizk. (2023) The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert Review of Pharmacoeconomics & Outcomes Research 23:4, pages 419-430.
Read now
Read now
Dirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, Gayane Melikyan, Hassan Al Hail, Lubna El-Sheikh, Musab Ali, Hassan Al Hussein, Faiza Ibrahim & Yolande Hanssens. (2019) Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview. Current Medical Research and Opinion 35:2, pages 249-260.
Read now
Read now
Saeed Taheri, Mohammad Ali Sahraian & Nazila Yousefi. (2019) Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison. Journal of Medical Economics 22:1, pages 71-84.
Read now
Read now
Natalie C. Edwards, Michael Munsell, Joseph Menzin & Amy L. Phillips. (2018) Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis. Current Medical Research and Opinion 34:8, pages 1389-1395.
Read now
Read now
Maurice Dahdaleh, Raed Alroughani, Mohammed Aljumah, Abdulrahman AlTahan, Issa Alsharoqi, Saeed A Bohlega, Abdulkader Daif, Dirk Deleu, Jihad Inshasi, Rana Karabudak, Mohammed A. Sahraian, Karim Taha, Bassem I. Yammout & Magd Zakaria. (2017) Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?. International Journal of Neuroscience 127:10, pages 944-951.
Read now
Read now
Dirk Deleu, Boulenouar Mesraoua, Hisham El Khider, Beatriz Canibano, Gayane Melikyan, Hassan Al Hail, Noha Mhjob, Anjushri Bhagat, Faiza Ibrahim & Yolande Hanssens. (2017) Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar. Current Medical Research and Opinion 33:3, pages 439-458.
Read now
Read now
Articles from other publishers (18)
Christos Bakirtzis, Maria Lima, Sotiria Stavropoulou De Lorenzo, Artemios Artemiadis, Paschalis Theotokis, Evangelia Kesidou, Natalia Konstantinidou, Styliani-Aggeliki Sintila, Marina-Kleopatra Boziki, Dimitrios Parissis, Panagiotis Ioannidis, Theodoros Karapanayiotides, Georgios Hadjigeorgiou & Nikolaos Grigoriadis. (2023) Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review. Healthcare 11:15, pages 2126.
Crossref
Crossref
Hussain Abdulrahman Al-Omar, Nada Alsowaida, Lama Aldosari, Ahmed Mayet, Reem Bunyan & Mohammed Aljumah. (2023) Exploring physicians’ prescribing behavior in patients with multiple sclerosis in Saudi Arabia: a sequential explanatory mixed-methods. BMC Neurology 23:1.
Crossref
Crossref
Wolfgang Reith, Alena Hausmann & Michael Kettner. (2022) Neue MRT-Leitlinien bei multipler SkleroseNew MRI guidelines for multiple sclerosis. Der Radiologe 62:4, pages 322-326.
Crossref
Crossref
Mahdi Barzegar, Soroush Najdaghi, Alireza Afshari-Safavi, Nasim Nehzat, Omid Mirmosayyeb & Vahid Shaygannejad. (2021) Early predictors of conversion to secondary progressive multiple sclerosis. Multiple Sclerosis and Related Disorders 54, pages 103115.
Crossref
Crossref
Mike P Wattjes, Olga Ciccarelli, Daniel S Reich, Brenda Banwell, Nicola de Stefano, Christian Enzinger, Franz Fazekas, Massimo Filippi, Jette Frederiksen, Claudio Gasperini, Yael Hacohen, Ludwig Kappos, David K B Li, Kshitij Mankad, Xavier Montalban, Scott D Newsome, Jiwon Oh, Jacqueline Palace, Maria A Rocca, Jaume Sastre-Garriga, Mar Tintoré, Anthony Traboulsee, Hugo Vrenken, Tarek Yousry, Frederik Barkhof, Àlex Rovira, Mike P Wattjes, Olga Ciccarelli, Nicola de Stefano, Christian Enzinger, Franz Fazekas, Massimo Filippi, Jette Frederiksen, Claudio Gasperini, Yael Hacohen, Ludwig Kappos, Kshitij Mankad, Xavier Montalban, Jacqueline Palace, María A Rocca, Jaume Sastre-Garriga, Mar Tintore, Hugo Vrenken, Tarek Yousry, Frederik Barkhof, Alex Rovira, David K B Li, Anthony Traboulsee, Scott D Newsome, Brenda Banwell, Jiwon Oh, Daniel S Reich, Daniel S Reich & Jiwon Oh. (2021) 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. The Lancet Neurology 20:8, pages 653-670.
Crossref
Crossref
Samia J Khoury & Mar Tintore. (2020) Multiple sclerosis in the Middle East and North Africa region. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:1, pages 205521731989554.
Crossref
Crossref
Maya M Zeineddine & Bassem I Yamout. (2020) Treatment of multiple sclerosis in special populations: The case of refugees. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:1, pages 205521731984846.
Crossref
Crossref
Antonia Ceccarelli, Victoria Mifsud, Eslam Abusamra & Syed Irteza Hussain. (2020) Short term real-world Fingolimod efficacy and safety in Emirati patients with multiple sclerosis. Journal of Clinical Neuroscience 71, pages 39-42.
Crossref
Crossref
Jeremy Hobart, Amy Bowen, George Pepper, Harriet Crofts, Lucy Eberhard, Thomas Berger, Alexey Boyko, Cavit Boz, Helmut Butzkueven, Elisabeth Gulowsen Celius, Jelena Drulovic, José Flores, Dana Horáková, Christine Lebrun-Frénay, Ruth Ann Marrie, James Overell, Fredrik Piehl, Peter Vestergaard Rasmussen, Maria José Sá, Carmen-Adella Sîrbu, Eli Skromne, Øivind Torkildsen, Vincent van Pesch, Timothy Vollmer, Magd Zakaria, Tjalf Ziemssen & Gavin Giovannoni. (2018) International consensus on quality standards for brain health-focused care in multiple sclerosis. Multiple Sclerosis Journal 25:13, pages 1809-1818.
Crossref
Crossref
Saeed Bohlega, Raed Alroughani, Mona Alkhawajah, Taoufik Alsaadi, Abdulkader Daif, Osama R. Elalamy, Jihad S. Inshasi, Suzan Noori, Mustafa Shakra, Ahmed O. Shatila, Ahmed El Boghdady & Amir Boshra. (2019) Expert opinion on clinical experience with subcutaneous interferon beta‐1a in multiple sclerosis patients with different disease activity profiles. Neurology and Clinical Neuroscience 7:5, pages 260-266.
Crossref
Crossref
Ali A. Asadi-Pooya, Mohamad Ali Sahraian, Farzad Sina, Seyed Mohammad Baghbanian, Jafar Mehvari Habibabadi, Vahid Shaygannejad, Marjan Asadollahi, Sanaz Ahmadi Karvigh, Abdorreza Naser Moghadasi, Alireza Nikseresht & Mahmoud Motamedi. (2019) Management of seizures in patients with multiple sclerosis; an Iranian consensus. Epilepsy & Behavior 96, pages 244-248.
Crossref
Crossref
G. Mathey, M. Michaud, S. Pittion-Vouyovitch & M. Debouverie. (2018) Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today?. Revue Neurologique 174:6, pages 378-390.
Crossref
Crossref
Xavier Montalban, Ralf Gold, Alan J Thompson, Susana Otero-Romero, Maria Pia Amato, Dhia Chandraratna, Michel Clanet, Giancarlo Comi, Tobias Derfuss, Franz Fazekas, Hans Peter Hartung, Eva Havrdova, Bernhard Hemmer, Ludwig Kappos, Roland Liblau, Catherine Lubetzki, Elena Marcus, David H Miller, Tomas Olsson, Steve Pilling, Krysztof Selmaj, Aksel Siva, Per Soelberg Sorensen, Maria Pia Sormani, Christoph Thalheim, Heinz Wiendl & Frauke Zipp. (2018) ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Multiple Sclerosis Journal 24:2, pages 96-120.
Crossref
Crossref
X. Montalban, R. Gold, A. J. Thompson, S. Otero‐Romero, M. P. Amato, D. Chandraratna, M. Clanet, G. Comi, T. Derfuss, F. Fazekas, H. P. Hartung, E. Havrdova, B. Hemmer, L. Kappos, R. Liblau, C. Lubetzki, E. Marcus, D. H. Miller, T. Olsson, S. Pilling, K. Selmaj, A. Siva, P. S. Sorensen, M. P. Sormani, C. Thalheim, H. Wiendl & F. Zipp. (2018)
ECTRIMS
/
EAN
guideline on the pharmacological treatment of people with multiple sclerosis
. European Journal of Neurology 25:2, pages 215-237.
Crossref
Crossref
Reza Rahmanzadeh, Abdureza N. Moghadasi, Samira Navardi, Alireza Minagar & Mohammad A. Sahraian. 2018. Neuroinflammation. Neuroinflammation
1
20
.
Serkan Demir, Eyup Duzgun, Cahit Kafadar, Erdem Togrol, Guney Senol & Akin Cakir. (2017) Evoked potentials and other guiding factors of conversion from radiologically isolated syndrome to definite multiple sclerosis. Medical Science and Discovery, pages 44-44.
Crossref
Crossref
Gavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, Jeremy Hobart, Gisela Kobelt, George Pepper, Maria Pia Sormani, Christoph Thalheim, Anthony Traboulsee & Timothy Vollmer. (2016) Brain health: time matters in multiple sclerosis. Multiple Sclerosis and Related Disorders 9, pages S5-S48.
Crossref
Crossref
Raed Alroughani, Ayse Altintas, Mohammed Al Jumah, Mohammadali Sahraian, Issa Alsharoqi, Abdurahman AlTahan, Abdulkader Daif, Maurice Dahdaleh, Dirk Deleu, Oscar Fernandez, Nikolaos Grigoriadis, Jihad Inshasi, Rana Karabudak, Karim Taha, Natalia Totolyan, Bassem I. Yamout, Magd Zakaria & Saeed Bohlega. (2016) Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks. Multiple Sclerosis International 2016, pages 1-8.
Crossref
Crossref